What is the pipeline for future medications for obesity? International Journal of Obesity Identification and utility exploration of a highly potent and long acting bullfrog GLP 1 analogue in GLP 1 and amylin combination therapy ScienceDirect Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Glucagon Like Peptide 1 Based Therapies: A New Horizon in Obesity Management GLP1 Receptor Agonist Mechanisms GLP1RAs mimic the effects of Human Glucagon Like Peptide1 (GLP1), 'fooling your body' into thinking you ingested more than you actually have, causing earlier onset fullness & eventual